China Money Network
Login
Join

C-Bridge Capital Leads $150M Round In Merged Chinese Drug Developer

  • March 23, 2017 — 18:08 CST

This Data Is Locked!

This area is available only to Subscribers.

C-Bridge Capital, a US$700 million-under-management healthcare private equity fund in China, has teamed up with Tianjin-based traditional Chinese medicine company Tasly Holding Group to invested... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: